Zhou L, Hu Y, Xiao H
BMC Cancer. 2021; 21(1):424.
PMID: 33863308
PMC: 8052826.
DOI: 10.1186/s12885-021-08170-3.
Rajanna V, Raveendranath M, Kathiresan S, Srinivasan S, Ilango J
J Pharm Bioallied Sci. 2020; 12(Suppl 1):S382-S388.
PMID: 33149491
PMC: 7595508.
DOI: 10.4103/jpbs.JPBS_114_20.
Troiano G, Guida A, Aquino G, Botti G, Losito N, Papagerakis S
Int J Mol Sci. 2018; 19(9).
PMID: 30205554
PMC: 6174346.
DOI: 10.3390/ijms19092664.
Santarelli A, Mascitti M, Russo L, Sartini D, Troiano G, Emanuelli M
Int J Mol Sci. 2018; 19(4).
PMID: 29587347
PMC: 5979467.
DOI: 10.3390/ijms19040971.
Basheer S, Shameena P, Sudha S, Varma S, Vidyanath S, Varekar A
J Oral Maxillofac Pathol. 2018; 21(3):456-457.
PMID: 29391729
PMC: 5763877.
DOI: 10.4103/jomfp.JOMFP_39_15.
Survivin expression, HPV positivity and microvessel density in oropharyngeal carcinomas and relationship with survival time.
Tastekin E, Caloglu V, Durankus N, Sut N, Turkkan G, Can N
Arch Med Sci. 2017; 13(6):1467-1473.
PMID: 29181079
PMC: 5701673.
DOI: 10.5114/aoms.2015.56616.
Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.
Wang X, Beitler J, Huang W, Chen G, Qian G, Magliocca K
Clin Cancer Res. 2017; 24(4):858-869.
PMID: 29180609
PMC: 5815948.
DOI: 10.1158/1078-0432.CCR-17-0345.
WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer.
Tiefenbock-Hansson K, Haapaniemi A, Farnebo L, Palmgren B, Tarkkanen J, Farnebo M
Oncol Rep. 2017; 38(4):2062-2068.
PMID: 28849066
PMC: 5652956.
DOI: 10.3892/or.2017.5898.
Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma.
Khan Z, Khan A, Yadav H, Prasad G, Bisen P
Cell Mol Biol Lett. 2017; 22:8.
PMID: 28536639
PMC: 5415770.
DOI: 10.1186/s11658-017-0038-0.
[Exploratory study on influence of biopsy to biological behavior of Tca8113 transplanted tumor].
Jiyuan L, Jian P, Chengge H, Yunlong W, Zhengwen L, Xiufa T
Hua Xi Kou Qiang Yi Xue Za Zhi. 2017; 34(6):626-631.
PMID: 28318166
PMC: 7030865.
DOI: 10.7518/hxkq.2016.06.015.
Expression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: a comparative immunohistochemical study.
Makboul R, Refaiy A, Badary F, Abdelkawi I, Merseburger A, Ahmed Mohammed R
Korean J Urol. 2015; 56(1):31-40.
PMID: 25598934
PMC: 4294853.
DOI: 10.4111/kju.2015.56.1.31.
Oncoapoptotic markers in oral cancer: prognostics and therapeutic perspective.
Jain A, Bundela S, Tiwari R, Bisen P
Mol Diagn Ther. 2014; 18(5):483-94.
PMID: 24838674
DOI: 10.1007/s40291-014-0104-5.
High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.
Erpolat O, Gocun P, Akmansu M, Karakus E, Akyol G
Strahlenther Onkol. 2012; 188(3):248-54.
PMID: 22311150
DOI: 10.1007/s00066-011-0042-7.
Odontogenic epithelium: immunolabeling of Ki-67, EGFR and survivin in pericoronal follicles, dentigerous cysts and keratocystic odontogenic tumors.
de Oliveira M, Lauxen I, Chaves A, Rados P, Filho M
Head Neck Pathol. 2010; 5(1):1-7.
PMID: 21053110
PMC: 3037468.
DOI: 10.1007/s12105-010-0216-0.
Biomolecular markers in cancer of the tongue.
Ferrari D, Codeca C, Fiore J, Moneghini L, Bosari S, Foa P
J Oncol. 2009; 2009:412908.
PMID: 19696947
PMC: 2728936.
DOI: 10.1155/2009/412908.
Upregulation of CENP-H in tongue cancer correlates with poor prognosis and progression.
Liao W, Yu C, Wu D, Zhang L, Xu L, Weng G
J Exp Clin Cancer Res. 2009; 28:74.
PMID: 19500341
PMC: 2706220.
DOI: 10.1186/1756-9966-28-74.
Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients.
Kobayashi J, Torigoe T, Hirohashi Y, Idenoue S, Miyazaki A, Yamaguchi A
J Transl Med. 2009; 7:1.
PMID: 19123955
PMC: 2627828.
DOI: 10.1186/1479-5876-7-1.
Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells.
Konopka K, Spain C, Yen A, Overlid N, Gebremedhin S, Duzgunes N
Cell Mol Biol Lett. 2008; 14(1):70-89.
PMID: 18839071
PMC: 6275586.
DOI: 10.2478/s11658-008-0034-5.
Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma.
de Maria S, Pannone G, Bufo P, Santoro A, Serpico R, Metafora S
J Cancer Res Clin Oncol. 2008; 135(1):107-16.
PMID: 18642030
DOI: 10.1007/s00432-008-0433-z.
Prognostic significance of Survivin and CD44v6 in laryngeal cancer surgical margins.
Zhao H, Ren J, Zhuo X, Ye H, Zou J, Liu S
J Cancer Res Clin Oncol. 2008; 134(10):1051-8.
PMID: 18414895
DOI: 10.1007/s00432-008-0391-5.